Taking thalidomide out of rehab

被引：13
作者：
Akhurst, Rosemary J. [1 ,2 ]
机构：
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
来源：
NATURE MEDICINE | 2010年 / 16卷 / 04期
关键词：
HEREDITARY HEMORRHAGIC TELANGIECTASIA; GROWTH-FACTOR-BETA; ANGIOGENESIS; MICE; BEVACIZUMAB; DEFECTS; VEGF;
D O I：
10.1038/nm0410-370
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Thalidomide, a drug reviled in the 1960s for its teratogenic effects, has been revived in recent years for cancer and leprosy therapy. A study now finds another use for this drug in vascular disease, providing further insights into the drug's mechanisms of action (pages 420-428).
引用
收藏
页码：370 / 372
页数：4
相关论文
共 13 条
  • [1] Potential role of modifier genes influencing transforming growth factor-β1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia
    Bourdeau, A
    Faughnan, ME
    McDonald, ML
    Paterson, AD
    Wanless, IR
    Letarte, M
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (06) : 2011 - 2020
  • [2] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS
    DAMATO, RJ
    LOUGHNAN, MS
    FLYNN, E
    FOLKMAN, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4082 - 4085
  • [3] DANIEL TO, 1987, J BIOL CHEM, V262, P11893
  • [4] DEEKEN JF, 2009, PHARMACOGENOMIC 1229, P29, DOI DOI 10.1038/TPJ.2009.57
  • [5] Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab
    Flieger, Dimitri
    Hainke, Sabine
    Fischbach, Wolfgang
    [J]. ANNALS OF HEMATOLOGY, 2006, 85 (09) : 631 - 632
  • [6] Gap junction communication mediates transforming growth factor-β activation and endothelial-induced mural cell differentiation
    Hirschi, KK
    Burt, JM
    Hirschi, KD
    Dai, CP
    [J]. CIRCULATION RESEARCH, 2003, 93 (05) : 429 - 437
  • [7] Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia
    Lebrin, Franck
    Srun, Samly
    Raymond, Karine
    Martin, Sabrina
    van den Brink, Stieneke
    Freitas, Catarina
    Breant, Christiane
    Mathivet, Thomas
    Larrivee, Bruno
    Thomas, Jean-Leon
    Arthur, Helen M.
    Westermann, Cornelis J. J.
    Disch, Frans
    Mager, Johannes J.
    Snijder, Repke J.
    Eichmann, Anne
    Mummery, Christine L.
    [J]. NATURE MEDICINE, 2010, 16 (04) : 420 - U101
  • [8] Li XP, 2003, ANTICANCER RES, V23, P2481
  • [9] Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia
    Mitchell, Andrew
    Adams, Leon A.
    Mac Uillan, Gerry
    Tibballs, Jon
    Driesen, Rohan Vanden
    Delriviere, Luc
    [J]. LIVER TRANSPLANTATION, 2008, 14 (02) : 210 - 213
  • [10] Genetic loci that control vascular endothelial growth factor-induced angiogenesis
    Rogers, MS
    Rohan, RM
    Birsner, AE
    D'Amato, RJ
    [J]. FASEB JOURNAL, 2003, 17 (12) : 2112 - +
12